— Know what they know.
Not Investment Advice

DNAG OTC

DNAPrint Genomics, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +100.0% 1Y: +100.0% 3Y: -80.0% 5Y: +100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 50 · $12892 mcap · 413M float · 0.079% daily turnover

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 22 Grade D
Profitability
20
Balance Sheet
37
Earnings Quality
36
Growth
55
Value
15
Momentum
56
Safety
0
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. DNAG scores highest in Momentum (56/100) and lowest in Safety (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-30.25
Distress Zone
Piotroski F-Score
3/9
✗ ✗ ✓ ✓ ✗ ✓ ✗ ✗ ✗
Beneish M-Score
6.19
Possible Manipulator
Ohlson O-Score
22.05
Bankruptcy prob: 100.0%
High Risk
Credit Rating
B-
Score: 20.0/100
Trend: Stable
Earnings Quality
—
OCF/NI: 0.91x
Accruals: -10.9%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. DNAG scores -30.25, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. DNAG scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. DNAG's score of 6.19 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. DNAG's implied 100.0% bankruptcy probability signals significant financial distress. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. DNAG receives an estimated rating of B- (score: 20.0/100), with a stable trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-0.00x
PEG
-0.00x
P/S
0.01x
P/B
-0.00x
P/FCF
-0.92x
P/OCF
—
EV/EBITDA
-1.80x
EV/Revenue
4.75x
EV/EBIT
-1.45x
EV/FCF
-2.13x
Earnings Yield
-114.60%
FCF Yield
-108.43%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. DNAG currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
—
NI / EBT
×
Interest Burden
-0.000
EBT / EBIT
×
EBIT Margin
-3.265
EBIT / Rev
×
Asset Turnover
0.514
Rev / Assets
×
Equity Multiplier
-0.520
Assets / Equity
=
ROE
63.1%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. DNAG's ROE of 63.1% is driven by Asset Turnover (0.514), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$0.00
Median 1Y
$0.00
5th Pctile
$0.00
95th Pctile
$0.00
Ann. Volatility
2296.8%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q4'02 Q1'03 Q2'03 Q3'03 Q4'03 Q1'04 Q2'04 Q3'04 Q4'04 Q1'05 Q2'05 Q3'05 Q4'05 Q1'06 Q2'06 Q3'06 Q4'06 Q1'07 Q2'07 Q3'07 Current
ROE 10.0% 8.7% 3.4% 4.4% 5.0% 6.3% 2.6% 3.7% 3.8% 3.4% 20.5% -45.0% 5.1% 15.4% 11.7% 4.9% 3.2% 1.9% 1.2% 63.1% 63.10%
ROA -4.6% -4.5% -6.5% -8.3% -9.1% -10.1% -7.7% -4.7% -2.4% -2.5% -2.1% -2.2% -2.5% -3.7% -2.5% -3.1% -1.5% -1.1% -1.1% -1.2% -1.21%
ROIC -8.3% -6.0% -1.2% -1.7% -3.4% -3.1% -4.2% -4.3% -10.3% -5.7% 1.1% 1.2% -76.3% 3.3% 2.7% 11.4% -1.4% -1.3% -3.1% -1.6% -1.56%
ROCE 2.4% 2.8% 1.4% 2.2% 5.0% 5.5% 5.1% 167.4% -15.2% 14.6% -3.3% -6.2% 1.2% 7.1% 2.9% 1.5% 2.5% 1.4% 1.1% 77.6% 77.59%
Gross Margin 94.0% 52.0% 62.3% 49.9% -26.2% 26.8% 36.6% 23.2% 60.4% 37.7% 25.4% 22.7% 20.0% 21.4% 36.3% 33.5% 34.4% 26.6% 18.0% -2.9% -2.90%
Operating Margin 14.0% 5.9% 10.3% 6.7% 11.0% 5.6% 2.7% 5.0% 4.5% 3.4% 2.6% 4.5% 4.1% 3.8% 3.1% 4.2% 3.3% 2.1% 3.1% 7.3% 7.31%
Net Margin -15.0% -9.3% -12.4% -6.9% -16.1% -5.7% -2.7% -5.1% -6.9% -3.8% -6.8% -6.3% -13.3% -4.1% -4.1% -5.1% -7.3% 4.1% -3.6% -8.3% -8.27%
EBITDA Margin -11.9% -4.8% -10.0% -6.4% -5.5% -2.7% -1.4% -4.6% -4.2% -2.9% -2.3% -3.6% 1.4% -2.1% -1.9% -3.4% -2.5% -1.4% -2.7% -6.6% -6.62%
FCF Margin -8.6% -7.8% -2.9% -1.8% -2.2% -2.3% -3.5% -4.6% -4.9% -4.8% -4.0% -3.6% -2.9% -3.1% -3.3% -2.9% -2.5% -2.1% -1.8% -2.2% -2.23%
OCF Margin -8.5% -7.7% -2.9% -1.8% -2.2% -2.2% -3.4% -4.5% -4.8% -4.7% -3.9% -3.6% -2.8% -2.9% -3.2% -2.8% -2.4% -2.0% -1.7% -2.1% -2.14%
ROA 3Y Avg snapshot only -1.99%
ROIC Economic snapshot only -1.61%
Cash ROA snapshot only -1.33%
NOPAT Margin snapshot only 2.58%
Pretax Margin snapshot only 0.00%
R&D / Revenue snapshot only 2.35%
SGA / Revenue snapshot only 1.15%
SBC / Revenue snapshot only 0.00%
Valuation
Metric Trend Q4'02 Q1'03 Q2'03 Q3'03 Q4'03 Q1'04 Q2'04 Q3'04 Q4'04 Q1'05 Q2'05 Q3'05 Q4'05 Q1'06 Q2'06 Q3'06 Q4'06 Q1'07 Q2'07 Q3'07 Current
P/E Ratio -4.47 -3.33 -7.59 -3.94 -4.63 -2.77 -2.91 -2.73 -2.50 -1.81 -2.24 -0.23 -0.39 -0.54 -0.47 -0.32 -0.32 -0.68 -0.77 -0.87 -0.001
P/S Ratio 75.49 56.08 99.53 39.92 50.86 27.28 19.80 17.57 11.89 7.62 12.72 1.37 3.09 3.79 2.94 1.90 1.61 1.86 1.96 2.06 0.005
P/B Ratio -12.61 -11.99 -12.64 -10.10 -17.72 -13.15 -12.11 -43.88 97.81 -23.35 12.36 2.40 -0.97 -5.03 -1.91 -0.71 -1.06 -0.79 -0.66 -0.47 -0.002
P/FCF -8.77 -7.23 -34.13 -21.81 -23.37 -12.04 -5.70 -3.85 -2.45 -1.59 -3.14 -0.37 -1.06 -1.24 -0.88 -0.65 -0.63 -0.87 -1.08 -0.92 -0.922
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA -6.83 -5.59 -10.08 -4.88 -7.06 -4.25 -5.43 -5.39 -3.94 -2.53 -4.49 -1.03 -1.53 -3.26 -3.43 -2.58 -0.45 -1.02 -1.69 -1.80 -1.799
EV/Revenue 80.13 59.06 100.02 39.78 51.66 27.25 20.33 16.96 11.45 7.44 14.19 3.16 2.52 5.43 5.59 4.81 1.11 2.34 4.16 4.75 4.745
EV/EBIT -5.66 -4.58 -9.10 -4.56 -5.88 -3.30 -3.47 -3.13 -2.70 -2.04 -4.02 -0.88 -0.69 -1.45 -1.48 -1.27 -0.30 -0.74 -1.33 -1.45 -1.453
EV/FCF -9.31 -7.61 -34.30 -21.74 -23.74 -12.02 -5.85 -3.71 -2.35 -1.55 -3.51 -0.87 -0.86 -1.77 -1.68 -1.64 -0.44 -1.10 -2.29 -2.13 -2.128
Earnings Yield -22.3% -30.0% -13.2% -25.4% -21.6% -36.1% -34.4% -36.6% -40.0% -55.4% -44.6% -4.3% -2.6% -1.9% -2.1% -3.1% -3.2% -1.5% -1.3% -1.1% -1.15%
FCF Yield -11.4% -13.8% -2.9% -4.6% -4.3% -8.3% -17.5% -26.0% -40.9% -62.9% -31.8% -2.7% -94.5% -80.8% -1.1% -1.5% -1.6% -1.1% -92.3% -1.1% -1.08%
EV/Gross Profit snapshot only 20.531
Acquirers Multiple snapshot only 1.453
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q4'02 Q1'03 Q2'03 Q3'03 Q4'03 Q1'04 Q2'04 Q3'04 Q4'04 Q1'05 Q2'05 Q3'05 Q4'05 Q1'06 Q2'06 Q3'06 Q4'06 Q1'07 Q2'07 Q3'07 Current
Current Ratio 0.02 0.04 0.11 0.14 0.39 0.38 0.30 0.85 0.89 0.69 0.46 0.34 0.25 0.20 0.23 0.07 0.64 0.44 0.31 0.17 0.168
Quick Ratio 0.02 0.04 0.11 0.14 0.39 0.38 0.30 0.85 0.85 0.62 0.41 0.29 0.22 0.19 0.22 0.05 0.63 0.42 0.29 0.14 0.142
Debt/Equity -0.79 -0.66 -0.19 -0.10 -0.41 -0.42 -0.46 -1.77 6.58 -1.96 1.95 3.61 -0.26 -2.67 -2.17 -1.12 -1.96 -1.05 -0.81 -0.64 -0.635
Net Debt/Equity — — — — — — — — -3.66 — 1.43 3.16 — — — — — — — — —
Debt/Assets 2.05 1.39 0.76 0.32 0.65 0.59 0.86 0.40 0.35 0.34 0.45 0.50 0.17 0.69 1.16 1.53 0.71 0.91 1.15 1.71 1.711
Debt/EBITDA -0.40 -0.29 -0.15 -0.05 -0.16 -0.13 -0.20 -0.22 -0.28 -0.22 -0.64 -0.67 -0.51 -1.21 -2.05 -1.59 -1.20 -1.08 -0.98 -1.05 -1.046
Net Debt/EBITDA -0.40 -0.28 -0.05 0.02 -0.11 0.01 -0.14 0.19 0.15 0.06 -0.47 -0.59 0.35 -0.98 -1.63 -1.57 0.20 -0.21 -0.89 -1.02 -1.019
Interest Coverage — — — — — — — — — — — — — — — — — — — — —
Equity Multiplier -0.38 -0.47 -0.25 -0.31 -0.63 -0.71 -0.53 -4.39 18.75 -5.72 4.37 7.17 -1.54 -3.87 -1.87 -0.73 -2.77 -1.16 -0.70 -0.37 -0.371
Cash Ratio snapshot only 0.012
Cash to Debt snapshot only 0.025
FCF to Debt snapshot only -0.808
Efficiency & Turnover
Metric Trend Q4'02 Q1'03 Q2'03 Q3'03 Q4'03 Q1'04 Q2'04 Q3'04 Q4'04 Q1'05 Q2'05 Q3'05 Q4'05 Q1'06 Q2'06 Q3'06 Q4'06 Q1'07 Q2'07 Q3'07 Current
Asset Turnover 0.27 0.27 0.49 0.82 0.83 1.02 1.12 0.73 0.51 0.59 0.37 0.37 0.31 0.52 0.40 0.53 0.29 0.42 0.45 0.51 0.514
Inventory Turnover — — — — — — — — 15.56 8.32 8.54 8.04 5.22 12.43 13.07 8.75 8.50 14.91 11.78 6.12 6.122
Receivables Turnover 38.40 8.53 13.75 15.33 75.04 21.62 10.25 12.98 29.72 9.11 6.60 13.77 17.54 8.35 11.88 14.98 27.58 9.92 13.71 13.44 13.440
Payables Turnover 0.17 0.14 0.08 0.16 0.70 0.91 0.34 0.45 1.09 1.09 1.29 1.76 1.26 1.71 2.85 1.34 0.81 0.79 0.95 0.64 0.641
DSO 10 43 27 24 5 17 36 28 12 40 55 26 21 44 31 24 13 37 27 27 27.2 days
DIO 0 0 0 0 0 0 0 0 23 44 43 45 70 29 28 42 43 24 31 60 59.6 days
DPO 2110 2678 4850 2225 525 399 1089 816 336 336 282 208 289 214 128 272 453 464 383 570 569.7 days
Cash Conversion Cycle -2100 -2635 -4823 -2202 -520 -382 -1054 -788 -300 -252 -184 -136 -198 -141 -69 -205 -396 -403 -325 -483 -482.9 days
Fixed Asset Turnover snapshot only 1.846
Operating Cycle snapshot only 86.8 days
Cash Velocity snapshot only 14.375
Capital Intensity snapshot only 1.612
Growth (YoY)
Metric Trend Q4'02 Q1'03 Q2'03 Q3'03 Q4'03 Q1'04 Q2'04 Q3'04 Q4'04 Q1'05 Q2'05 Q3'05 Q4'05 Q1'06 Q2'06 Q3'06 Q4'06 Q1'07 Q2'07 Q3'07 Current
Revenue 90.4% 1.5% 2.4% 3.6% 2.8% 3.5% 1.2% 28.5% 10.7% -2.6% 3.4% 31.5% 62.4% 1.1% 1.2% 1.2% 90.7% 43.3% 21.3% -15.2% -15.16%
Net Income -1.7% -75.4% -82.6% -80.4% -1.5% -1.6% -12.1% 18.4% 52.1% 58.2% 13.9% -21.3% -1.7% -2.5% -1.4% -1.2% -21.5% 44.4% 50.1% 66.1% 66.05%
EPS -1.4% -58.5% -64.6% -58.0% -1.2% -1.3% 20.4% 42.9% 70.5% 77.0% 48.2% 43.8% 38.5% 38.9% 62.1% 56.3% 46.9% 68.3% 68.5% 78.9% 78.87%
FCF -1.6% -53.8% 17.8% 34.9% 2.8% -31.2% -1.6% -2.2% -1.5% -1.1% -20.4% -5.0% 2.4% -33.6% -79.4% -75.9% -65.5% 0.2% 34.0% 35.6% 35.64%
EBITDA -1.6% -41.9% -1.0% -1.1% -1.4% -1.7% 18.7% 50.4% 56.1% 55.3% 12.7% -27.9% 7.9% -18.5% -12.2% -32.8% -1.9% -96.7% -83.3% -20.2% -20.19%
Op. Income 1.4% 38.1% 82.7% 80.3% 1.4% 1.9% 14.9% -20.0% -46.5% -56.9% -37.7% -12.7% 39.8% 1.2% 1.3% 1.3% 90.2% 20.1% 0.3% -27.0% -27.02%
OCF Growth snapshot only 35.51%
Asset Growth snapshot only -29.16%
Debt Growth snapshot only -21.02%
Shares Change snapshot only 60.63%
Growth (CAGR)
Metric Trend Q4'02 Q1'03 Q2'03 Q3'03 Q4'03 Q1'04 Q2'04 Q3'04 Q4'04 Q1'05 Q2'05 Q3'05 Q4'05 Q1'06 Q2'06 Q3'06 Q4'06 Q1'07 Q2'07 Q3'07 Current
Revenue 3Y — — — — — — — — 6.3% 1.2% 96.7% 98.1% 90.5% 1.1% 69.3% 54.5% 50.8% 42.9% 39.8% 34.5% 34.51%
Revenue 5Y — — — — — — — — — — — — — — — — 3.1% 1.0% 82.2% 70.5% 70.45%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — 4.2% 97.8% 74.9% 73.3% 42.9% 50.2% 25.2% 21.1% 39.6% 39.4% 41.7% 41.6% 41.57%
Gross Profit 5Y — — — — — — — — — — — — — — — — 2.3% 81.4% 64.2% 47.4% 47.40%
Op. Income 3Y — — — — — — — — 44.4% 19.6% 9.4% 8.0% 21.3% 38.6% 18.7% 17.1% 12.5% 3.6% 13.4% 13.6% 13.57%
Op. Income 5Y — — — — — — — — — — — — — — — — 51.6% 34.6% 25.1% 16.1% 16.13%
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y — — — — — — — — 24.1% 15.8% 69.0% 78.9% 1.5% 1.3% 92.3% 78.8% 99.7% 75.7% 87.6% 30.7% 30.71%
Assets 5Y — — — — — — — — — — — — — — — — 61.4% 46.6% 42.9% 33.2% 33.19%
Equity 3Y — — — — — — — — -41.8% — 1.7% — — — — — — — — — —
Book Value 3Y — — — — — — — — -54.1% — 96.8% — — — — — — — — — —
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q4'02 Q1'03 Q2'03 Q3'03 Q4'03 Q1'04 Q2'04 Q3'04 Q4'04 Q1'05 Q2'05 Q3'05 Q4'05 Q1'06 Q2'06 Q3'06 Q4'06 Q1'07 Q2'07 Q3'07 Current
Revenue Stability — — — — 0.93 0.86 0.98 0.93 0.92 0.84 0.92 0.95 0.94 0.88 0.85 0.81 0.87 0.91 0.92 0.86 0.856
Earnings Stability — — — — 0.95 0.90 0.90 0.34 0.33 0.21 0.50 0.48 0.64 0.59 0.69 0.67 0.79 0.41 0.37 0.18 0.178
Margin Stability — — — — 0.53 0.74 0.61 0.52 0.49 0.74 0.62 0.56 0.63 0.60 0.53 0.51 0.34 0.68 0.72 0.64 0.640
Rev. Growth Consistency 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 0.00 1.00 1.00 1.00 0.50 1.00 1.00 1.00 1.00 1.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.500
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence — — — — 0.50 0.50 0.95 0.93 0.50 0.50 0.94 0.91 0.50 0.50 0.50 0.50 0.91 0.82 0.50 0.50 0.500
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend — — — — — — — — — — — — — — — — — — — — —
Gross Margin Trend — — — — -0.41 -0.22 -0.29 -0.34 -0.14 -0.09 -0.12 -0.07 -0.12 -0.14 -0.05 0.02 0.01 0.02 -0.01 -0.07 -0.071
FCF Margin Trend — — — — 154.08 7.96 4.03 2.81 0.53 0.22 -0.85 -0.45 0.60 0.47 0.43 1.17 1.36 1.80 1.87 1.06 1.063
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q4'02 Q1'03 Q2'03 Q3'03 Q4'03 Q1'04 Q2'04 Q3'04 Q4'04 Q1'05 Q2'05 Q3'05 Q4'05 Q1'06 Q2'06 Q3'06 Q4'06 Q1'07 Q2'07 Q3'07 Current
OCF/Net Income 0.50 0.46 0.22 0.18 0.20 0.23 0.50 0.70 1.01 1.12 0.69 0.60 0.35 0.42 0.52 0.48 0.47 0.74 0.67 0.91 0.910
FCF/OCF 1.01 1.00 1.00 1.01 1.01 1.01 1.01 1.01 1.02 1.01 1.03 1.03 1.03 1.04 1.03 1.04 1.07 1.06 1.06 1.04 1.040
FCF/Net Income snapshot only 0.946
CapEx/Revenue 8.9% 1.4% 0.0% 0.0% 1.1% 1.4% 2.8% 6.5% 7.3% 6.5% 4.5% 2.0% 3.7% 8.6% 9.8% 11.9% 16.1% 12.0% 10.7% 8.5% 8.54%
CapEx/Depreciation snapshot only 0.203
Accruals Ratio -2.27 -2.44 -5.04 -6.79 -7.32 -7.77 -3.79 -1.42 0.02 0.30 -0.66 -0.88 -1.62 -2.15 -1.20 -1.62 -0.79 -0.30 -0.38 -0.11 -0.109
Sloan Accruals snapshot only -0.229
Cash Flow Adequacy snapshot only -25.096
Dividends & Buybacks
Metric Trend Q4'02 Q1'03 Q2'03 Q3'03 Q4'03 Q1'04 Q2'04 Q3'04 Q4'04 Q1'05 Q2'05 Q3'05 Q4'05 Q1'06 Q2'06 Q3'06 Q4'06 Q1'07 Q2'07 Q3'07 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — — — — —
FCF Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Total Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -2.1% -0.2% -0.1% -1.1% -1.0% -6.4% -12.9% -26.8% -49.5% -66.1% -36.7% -2.8% -1.1% -87.4% -95.9% -97.7% -77.5% -39.4% -29.8% -26.7% -26.69%
Total Shareholder Return -2.1% -0.2% -0.1% -1.1% -1.0% -6.4% -12.9% -26.8% -49.5% -66.1% -36.7% -2.8% -1.1% -87.4% -95.9% -97.7% -77.5% -39.4% -29.8% -26.7% -26.69%
DuPont Factors
Metric Trend Q4'02 Q1'03 Q2'03 Q3'03 Q4'03 Q1'04 Q2'04 Q3'04 Q4'04 Q1'05 Q2'05 Q3'05 Q4'05 Q1'06 Q2'06 Q3'06 Q4'06 Q1'07 Q2'07 Q3'07 Current
Tax Burden (NI/EBT) — — — — — — — 6.04 4.41 4.09 5.98 — — — — — — — — — —
Interest Burden (EBT/EBIT) -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 0.20 0.25 0.28 0.27 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.000
EBIT Margin -14.16 -12.89 -10.99 -8.72 -8.79 -8.26 -5.85 -5.43 -4.24 -3.65 -3.53 -3.60 -3.65 -3.76 -3.79 -3.80 -3.64 -3.15 -3.13 -3.27 -3.265
Asset Turnover 0.27 0.27 0.49 0.82 0.83 1.02 1.12 0.73 0.51 0.59 0.37 0.37 0.31 0.52 0.40 0.53 0.29 0.42 0.45 0.51 0.514
Equity Multiplier -2.19 -1.92 -0.52 -0.53 -0.54 -0.63 -0.34 -0.78 -1.59 -1.37 -9.66 20.52 -2.03 -4.19 -4.64 -1.59 -2.13 -1.66 -1.05 -0.52 -0.520
Per Share
Metric Trend Q4'02 Q1'03 Q2'03 Q3'03 Q4'03 Q1'04 Q2'04 Q3'04 Q4'04 Q1'05 Q2'05 Q3'05 Q4'05 Q1'06 Q2'06 Q3'06 Q4'06 Q1'07 Q2'07 Q3'07 Current
EPS (Diluted TTM) $-0.13 $-0.13 $-0.22 $-0.24 $-0.30 $-0.30 $-0.17 $-0.14 $-0.09 $-0.07 $-0.09 $-0.08 $-0.05 $-0.04 $-0.03 $-0.03 $-0.03 $-0.01 $-0.01 $-0.01 $-0.01
Book Value/Share $-0.05 $-0.04 $-0.13 $-0.10 $-0.08 $-0.06 $-0.04 $-0.01 $0.00 $-0.01 $0.02 $0.01 $-0.02 $-0.00 $-0.01 $-0.02 $-0.01 $-0.01 $-0.01 $-0.01 $-0.01
Tangible Book/Share $-0.05 $-0.04 $-0.13 $-0.10 $-0.08 $-0.06 $-0.04 $-0.01 $0.00 $-0.01 $0.01 $0.00 $-0.02 $-0.01 $-0.01 $-0.02 $-0.01 $-0.01 $-0.01 $-0.01 $-0.01
Revenue/Share $0.01 $0.01 $0.02 $0.02 $0.03 $0.03 $0.03 $0.02 $0.02 $0.02 $0.02 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.00 $0.00 $0.00 $0.01
FCF/Share $-0.07 $-0.06 $-0.05 $-0.04 $-0.06 $-0.07 $-0.09 $-0.10 $-0.09 $-0.08 $-0.06 $-0.05 $-0.02 $-0.02 $-0.02 $-0.02 $-0.01 $-0.01 $-0.01 $-0.01 $-0.02
OCF/Share $-0.07 $-0.06 $-0.05 $-0.04 $-0.06 $-0.07 $-0.09 $-0.10 $-0.09 $-0.08 $-0.06 $-0.05 $-0.02 $-0.02 $-0.02 $-0.02 $-0.01 $-0.01 $-0.01 $-0.01 $-0.02
Cash/Share $0.00 $0.00 $0.02 $0.01 $0.01 $0.03 $0.01 $0.03 $0.02 $0.01 $0.01 $0.00 $0.01 $0.00 $0.00 $0.00 $0.02 $0.01 $0.00 $0.00 $0.02
EBITDA/Share $-0.09 $-0.08 $-0.16 $-0.20 $-0.20 $-0.20 $-0.09 $-0.07 $-0.05 $-0.05 $-0.05 $-0.04 $-0.01 $-0.01 $-0.01 $-0.01 $-0.01 $-0.01 $-0.01 $-0.01 $-0.01
Debt/Share $0.04 $0.02 $0.02 $0.01 $0.03 $0.03 $0.02 $0.02 $0.01 $0.01 $0.03 $0.03 $0.01 $0.01 $0.02 $0.02 $0.02 $0.01 $0.01 $0.01 $0.01
Net Debt/Share $0.04 $0.02 $0.01 $-0.00 $0.02 $-0.00 $0.01 $-0.01 $-0.01 $-0.00 $0.02 $0.02 $-0.00 $0.01 $0.01 $0.02 $-0.00 $0.00 $0.01 $0.01 $0.01
Academic Models
Metric Trend Q4'02 Q1'03 Q2'03 Q3'03 Q4'03 Q1'04 Q2'04 Q3'04 Q4'04 Q1'05 Q2'05 Q3'05 Q4'05 Q1'06 Q2'06 Q3'06 Q4'06 Q1'07 Q2'07 Q3'07 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — -30.250
Altman Z-Prime snapshot only -81.364
Piotroski F-Score 2 2 3 5 4 4 3 3 4 4 4 2 2 1 3 3 5 5 5 3 3
Beneish M-Score 2.98 -21.39 -23.23 -23.53 -12.15 -25.19 -16.13 -7.09 -3.49 2.54 28.37 64.93 54.19 55.96 -7.43 -9.66 -5.93 -4.27 11.02 6.19 6.192
Ohlson O-Score snapshot only 22.050
Net-Net WC snapshot only $-0.02
Credit
Metric Trend Q4'02 Q1'03 Q2'03 Q3'03 Q4'03 Q1'04 Q2'04 Q3'04 Q4'04 Q1'05 Q2'05 Q3'05 Q4'05 Q1'06 Q2'06 Q3'06 Q4'06 Q1'07 Q2'07 Q3'07 Current
Credit Rating snapshot only B-
Credit Score 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 33.57 20.00 33.49 32.10 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.000
Credit Grade snapshot only 16
Credit Trend snapshot only 0.000
Implied Spread (bps) snapshot only 900.000
Industry Credit Rank snapshot only 20
Sector Credit Rank snapshot only 19

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms